Overview

A Study of TRS01 in Participants With Post-surgical Ocular Inflammation

Status:
Completed
Trial end date:
2020-07-17
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and preliminary efficacy of TRS01 eye drops as compared to placebo on participants with ocular inflammation after cataract surgery.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tarsier Pharma
Tarsius Pharma
Treatments:
Ophthalmic Solutions